Stephen Basil Thomas - Jun 27, 2024 Form 3 Insider Report for Eliem Therapeutics, Inc. (ELYM)

Role: Director
Signature: /s/ Emily Pimblett, Attorney-in-Fact
Stock symbol: ELYM
Transactions as of: Jun 27, 2024
Transactions value $: $0
Form type: 3
Date filed: 6/27/2024, 07:01 PM

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 - Power of Attorney